Abstract
Reporting of suspected adverse reactions to drugs in the UK; Spontaneous reporting scheme (reporting primarily by patients in contrast to active drug safety monitoring, prescription-event monitoring by health professionals) established 1964 and operated by the MHRA in UK; the system is completely voluntary whereby physicians but also dentists, coronors and patients are encouraged to report (other countries accept only reporting of side effects by health care professionals); incomplete information provided often limit it’s use; other reporting systems are e.g., the Canadian Adverse Reaction Monitoring Program (CADRMP) or the Adverse Event Reporting System (AERS) of the U.S.; see also Black Triangle, case-control study, epidemiology, EudraVigilance, MedWatch, pharmacovigilance, who collaborating centre for international drug monitoring.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Nahler, G. (2017). Y. In: Dictionary of Pharmaceutical Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-50669-2_25
Download citation
DOI: https://doi.org/10.1007/978-3-319-50669-2_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50668-5
Online ISBN: 978-3-319-50669-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)